FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Skips Foreign Inspection Hearing

FDA declines to appear before the House Energy and Commerce Oversight and Investigations Subcommittee as it holds a critical hearing on the agencys fo...

latest-news-card-1
Medical Devices

Percussionaire Recalls Breathing Circuit Kits

Percussionaire recalls its High Frequency Transport Phasitron Breathing Circuit Kits due to a product defect that causes over-pressurization.

Biologics

Valneva Sells FDA Voucher for $103 Million

Valneva says it has sold an FDA tropical disease priority review voucher for $103 million that it will use to fund research and development efforts.

latest-news-card-1
Medical Devices

Boston Scientifics Spinal Cord Stimulator Wins 50% Pain Cut OK

FDA approves a 50% pain reduction indication for Boston Scientifics WaveWriter Spinal Cord Stimulator in treating chronic low back and leg pain.

latest-news-card-1
Federal Register

Guide on Reporting Drug Making Amounts

Federal Register notice: FDA makes available a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3...

latest-news-card-1
Human Drugs

FDA Again Cites Catalent Facility

Bloomberg News reports that FDA inspectors found problems at a Catalent Indiana facility that is being bought by Novo Nordisk to expand the supply of ...

latest-news-card-1
Human Drugs

Study on Enhancing Weight-Loss Drugs

FDA approves a Veru IND to begin a Phase 2b clinical study to evaluate enobosarm and its use in preserving muscle mass and physical function and incre...

latest-news-card-1
Human Drugs

Insight Recalls TING Athletes Foot Spray

Insight Pharmaceuticals recalls two lots of its TING 1% Tolnaftate Athletes Foot Spray Antifungal Spray Liquid due to elevated benzene levels.

latest-news-card-1
Human Drugs

Centera, CEO Sentenced Over Unapproved Drugs

A federal court sentences Arizona-based Centera Bioscience and CEO Paul Eftang for distributing unapproved drugs into interstate commerce.

latest-news-card-1
Human Drugs

J&J Reports Positive Data on Nipocalimab

Johnson & Johnson reports positive data from two studies involving its monoclonal antibody nipocalimab, supporting the drugs potential use in generali...